Table 2.
Basic characteristics of remission and no-remission groups.
| Remission group | No-remission group | P | ||
|---|---|---|---|---|
| Gender; no. of patients (%) | 0.042 |
|||
| Female | 9 (20.9%) | 29 (41.4%) | ||
| Male | 34 (79.1%) | 41 (58.6%) | ||
| Age; years | 65.8 ± 12.8 (n = 43) | 68.6 ± 11.0 (n = 70) | 0.221 | |
| Underlying disease; no. of patients (%) | 0.421 |
|||
| Non-diabetic | 31 (72.1%) | 44 (62.9%) | ||
| Diabetic | 12 (27.9%) | 26 (37.1%) | ||
| CKD stage; no. of patients (%) | 0.194 |
|||
| III | 5 (11.6%) | 3 (4.3%) | ||
| IV | 25 (58.1%) | 37 (52.9%) | ||
| V | 13 (30.2%) | 30 (42.9%) | ||
| eGFR; mL/min/1.73 m2 | 20.8 ± 8.6 (n = 43) | 17.3 ± 6.1 (n = 70) | 0.026 | |
| serum creatinine; mg/dL | 3.0 ± 1.5 (n = 43) | 3.0 ± 1.0 (n = 70) | 0.914 | |
| Total protein; g/dL | 7.2 ± 0.7 (n = 41) | 7.0 ± 0.7 (n = 69) | 0.126 | |
| Albumin; g/dL | 3.9 ± 0.6 (n = 39) | 3.8 ± 0.5 (n = 66) | 0.697 | |
| Urea nitrogen; mg/dL | 38.7 ± 13.1 (n = 42) | 40.6 ± 11.8 (n = 69) | 0.433 | |
| Uric acid; mg/dl | 7.4 ± 2.0 (n = 43) | 7.0 ± 1.6 (n = 68) | 0.239 | |
| Calcium; mg/dL | 9.0 ± 0.9 (n = 39) | 8.8 ± 0.6 (n = 64) | 0.181 | |
| Inorganic phosphate; mg/dL | 3.7 ± 0.8 (n = 35) | 4.0 ± 0.8 (n = 60) | 0.201 | |
| Total cholesterol; mg/dL | 200.5 ± 44.8 (n = 38) | 196.3 ± 46.3 (n = 63) | 0.652 | |
| Urinary protein; g/g·Cr | 2.1 ± 2.9 (n = 33) | 3.6 ± 3.2 (n = 48) | 0.036 | |
| Hemoglobin A1c; % | 6.5 ± 1.8 (n = 23) | 6.2 ± 1.2 (n = 34) | 0.400 | |
| Hemoglobin; g/dL | 11.6 ± 2.0 (n = 41) | 10.7 ± 1.9 (n = 69) | 0.013 | |
| Hematocrit; % | 35.7 ± 5.7 (n = 41) | 32.9 ± 5.3 (n = 69) | 0.009 |
Data are presented in means ± SD, unless stated otherwise. eGFR: estimated glomerular filtration rate.